Dumusc, A., Ng, W.-F., James, K., Griffiths, B., Price, E., Pease, C. T., Emery, P., Lanyon, P., Jones, A., Bombardieri, M., Sutcliffe, N., Pitzalis, C., Gupta, M., McLaren, J., Cooper, A., Giles, I., Isenberg, D., Saravanan, V., Coady, D., Dasgupta, B., McHugh, N., Young-Min, S., Moots, R. J., Gendi, N., Akil, M., Barone, F., Fisher, B. A., Rauz, S., Richards, A., Bowman, S. J. and on behalf of the UK primary Sjögren’s Syndrome Registry (2018) “Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren’s syndrome: examination of data from the UK Primary Sjögren’s Syndrome Registry”, Swiss Medical Weekly, 148(0506), p. w14588. doi: 10.4414/smw.2018.14588.